Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 50 entries
View as:

Association Between Patients' Perceptions of Success in Post-op Pain Management and Overall Experience With Care

Phase: N/A Priority: Normal
NCT ID: NCT02389907 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

Study Of Angiomax In Infants Under Six Months With Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT00043277 Org: User:
Start: 08/31/02 End: 12/31/04 Due: 12/31/05

Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

Phase: N/A Priority: Normal
NCT ID: NCT03397121 Org: User:
Start: 11/28/17 End: 09/17/19 Due: 09/17/20

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT03399370 Org: User:
Start: 12/21/17 End: 09/17/19 Due: 09/17/20

Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)

Phase: N/A Priority: Normal
NCT ID: NCT00093925 Org: User:
Start: 05/31/04 End: 09/30/06 Due: 09/30/07

European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

Phase: N/A Priority: Normal
NCT ID: NCT01087723 Org: User:
Start: 03/31/10 End: 08/31/14 Due: 08/31/15

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Phase: N/A Priority: Normal
NCT ID: NCT00043940 Org: User:
Start: 04/30/99 End: - Due: -

Cangrelor Prasugrel Transition Study

Phase: N/A Priority: Normal
NCT ID: NCT01852019 Org: User:
Start: 06/30/13 End: 07/31/13 Due: 07/31/14

Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT01860105 Org: User:
Start: 09/30/12 End: 01/31/13 Due: 01/31/14

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Phase: N/A Priority: Normal
NCT ID: NCT02597127 Org: User:
Start: 01/31/16 End: 06/07/17 Due: 06/07/18

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Phase: N/A Priority: Normal
NCT ID: NCT02452918 Org: User:
Start: 09/29/15 End: 07/05/16 Due: 07/05/17

Clevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)

Phase: N/A Priority: Normal
NCT ID: NCT00369837 Org: User:
Start: 09/30/06 End: 02/28/07 Due: 02/28/08

Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI

Phase: N/A Priority: Normal
NCT ID: NCT00093184 Org: User:
Start: 04/30/04 End: 12/31/05 Due: 12/31/06

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Phase: N/A Priority: Normal
NCT ID: NCT02925416 Org: User:
Start: 01/24/17 End: 06/20/17 Due: 06/20/18

Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)

Phase: N/A Priority: Normal
NCT ID: NCT00093249 Org: User:
Start: 01/31/04 End: 11/30/04 Due: 11/30/05

Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)

Phase: N/A Priority: Normal
NCT ID: NCT00093262 Org: User:
Start: 12/31/03 End: 10/31/04 Due: 10/31/05

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

Phase: N/A Priority: Normal
NCT ID: NCT00079586 Org: User:
Start: 04/30/04 End: 11/30/04 Due: 11/30/05

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01535222 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

Bivalirudin Infusion for Ventricular Infarction Limitation

Phase: N/A Priority: Normal
NCT ID: NCT02565147 Org: User:
Start: 12/19/14 End: 06/14/16 Due: 06/14/17

A Clinical Trial to Demonstrate the Efficacy of Cangrelor

Phase: N/A Priority: Normal
NCT ID: NCT00305162 Org: User:
Start: 04/30/06 End: 06/30/10 Due: 06/30/11

Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.

Phase: N/A Priority: Normal
NCT ID: NCT00385138 Org: User:
Start: 09/30/06 End: 06/30/10 Due: 06/30/11

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Phase: N/A Priority: Normal
NCT ID: NCT00073580 Org: User:
Start: 10/31/03 End: - Due: -

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

Phase: N/A Priority: Normal
NCT ID: NCT00666328 Org: User:
Start: 06/30/08 End: 04/30/10 Due: 04/30/11

A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Phase: N/A Priority: Normal
NCT ID: NCT02963311 Org: User:
Start: 12/13/16 End: 10/08/18 Due: 10/08/19

Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)

Phase: N/A Priority: Normal
NCT ID: NCT00093912 Org: User:
Start: 06/30/04 End: 11/30/06 Due: 11/30/07